Can Hormones Fix Fatigue and Weight Gain?
You went through menopause and the rules changed. The weight arrives without any change in what you eat. The fatigue is heavy enough that the workout you used to do feels out of reach. You mention it and get told your labs are normal.
Then you find a doctor who runs sixty tests, finds what everyone else missed, and puts you on thyroid medication, testosterone, estrogen, and progesterone. Within weeks the weight moves and the energy comes back. It is very hard to argue with results you can feel.
Dr. Joel Fuhrman and Dr. Cara Fuhrman ask the harder question: what are those results costing you? Relieving genuine menopausal symptoms with the lowest effective dose of hormones is one decision. Using hormones to lose weight and buy energy is a different one — and it carries a different risk.
Related: Do Women Really Need Hormone Replacement Therapy? (Part 1)
What You’ll Learn
- Why weight gain and fatigue aren’t the same case for hormones as hot flashes
- What reverse T3 and “cellular hypothyroidism” actually mean
- Why a TSH below 2 may be a warning rather than a win
- What testosterone and thyroid hormone do together
- Why a faster metabolism works against longevity
- What the DUTCH and OAT panels can and can’t tell you
- How to wean down safely if you’re already on high doses
- Where bone building fits between 35 and 50
3 Key Takeaways
1. Hormones for symptoms and hormones for weight loss are two different decisions.
Relieving hot flashes, disrupted sleep, brain fog, vaginal dryness, or diagnosed HSDD with the lowest effective dose is a defensible use of hormone therapy in a healthy woman. Prescribing testosterone and thyroid hormone to move the scale is not the same decision and does not carry the same risk profile. Testosterone raises red blood cell count and platelet stickiness. Thyroid hormone beyond what the body needs raises the risk of atrial fibrillation and sudden cardiac death. Even within the normal range of free T4, the highest values carry roughly double the heart attacks of the lowest. [CITATION NEEDED]
2. A faster metabolism is not the goal.
The most consistently supported strategy for extending lifespan is a lower metabolic rate — fewer calories of extremely nutrient-dense food, while holding muscle and not becoming too thin. Prescribing thyroid hormone and testosterone to speed metabolism so a person can keep eating 1,600 calories of standard American food runs in exactly the opposite direction. It produces a real result on the scale and an accelerated rate of aging underneath it. And once thyroid and testosterone push a woman’s balance androgenic, the estrogen dose goes up to compensate — so the whole stack climbs together.
3. The root cause is still what’s on the plate.
Lowering the cutoff for “normal” thyroid function doesn’t uncover a hidden disease. It widens the pool of people who can be prescribed what amounts to a metabolic stimulant. The panels are impressive and the results feel like answers. But across 2,000 people at the Fuhrman retreat over seven years — 60% women, most more than 50 pounds overweight — weight loss never required a hormone. Women averaged roughly 15 pounds the first month and about 10 per month after; men about 20, then 15. [VERIFY FIGURES] No hormone, supplement, or IV substitutes for a nutrient-dense diet.
Episode Chapters
00:00 Helpful or Harmful?
01:07 What Hormones Are For
02:56 Starting in Your 30s
04:57 “I Can’t Lose Weight”
07:29 Moving the Thyroid Cutoffs
08:52 Testosterone Plus Thyroid
12:22 The New Ozempic
14:10 Doctors Don’t Want to Change
15:28 Faster Metabolism, Faster Aging
19:43 The Sixty-Lab Illusion
23:13 Animal Protein and Early Death
27:13 Regenerative Therapy Instead
29:00 Talking to Your Doctor
31:00 “Board-Certified” in What?
32:24 Weaning Down Safely
- Liu Y, Guo Z. Dietary interventions and nutritional strategies for menopausal health: a mini review. Frontiers in Nutrition 2025, Volume 12 - 2025.
- Barnard ND, Kahleova H, Holtz DN, et al. A dietary intervention for vasomotor symptoms of menopause: a randomized, controlled trial. Menopause 2023, 30:80-87.
- Cleary MP, Grossmann ME. Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology 2009, 150:2537-2542.
- Bano A, Dhana K, Chaker L, et al. Association of Thyroid Function With Life Expectancy With and Without Cardiovascular Disease: The Rotterdam Study. JAMA Intern Med 2017, 177:1650-1657.
- Bano A, Chaker L, Mattace-Raso FUS, et al. Thyroid Function and the Risk of Atherosclerotic Cardiovascular Morbidity and Mortality: The Rotterdam Study. Circ Res 2017, 121:1392-1400.
- Barrantes-Espinola G, Alberti P, Jaramillo-Morales E, et al. Isocaloric substitution of animal protein with plant protein and its impact on all-cause, cardiovascular, and cancer mortality: A systematic review and meta-analysis. Clinical Nutrition 2026.
- Barnard ND, Kahleova H, Holtz DN, et al. A dietary intervention for vasomotor symptoms of menopause: a randomized, controlled trial. Menopause 2023, 30:80-87.
- Cleary MP, Grossmann ME. Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology 2009, 150:2537-2542.
- Bano A, Dhana K, Chaker L, et al. Association of Thyroid Function With Life Expectancy With and Without Cardiovascular Disease: The Rotterdam Study. JAMA Intern Med 2017, 177:1650-1657.
- Bano A, Chaker L, Mattace-Raso FUS, et al. Thyroid Function and the Risk of Atherosclerotic Cardiovascular Morbidity and Mortality: The Rotterdam Study. Circ Res 2017, 121:1392-1400.
- Barrantes-Espinola G, Alberti P, Jaramillo-Morales E, et al. Isocaloric substitution of animal protein with plant protein and its impact on all-cause, cardiovascular, and cancer mortality: A systematic review and meta-analysis. Clinical Nutrition 2026, 61.